Preventive Inhalation of Hypertonic Saline in Infants With Cystic Fibrosis
Status:
Completed
Trial end date:
2017-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess whether 6% hypertonic saline (HS) is a safe and
effective preventive therapy in newborns and infants with cystic fibrosis (CF).